CCL28 and disease arising from reactivation of latent virus: Compared with CCL19, here we found that CCL28 has an advantage in inducing long-lasting serum neutralizing Abs postchallenge and more potent systemic Abs, which may be the dominant reason for the rapid removal of HSV-2 after challenge and the reduction in establishing latent infection.